NCT05098613NCT05442515NCT06559189B-cell malignanciesChimeric antigen receptor (CAR) T-cell therapy
… configurations and is currently under clinical investigation ( NCT05098613, NCT05442515, NCT06559189). We hypothesized that simultaneous a…
5,089articles mentioning funders
9,137funder mentions
3,238distinct funders extracted
0%of mentions human-reviewed
All extracted funders
Showing 61–120 of 3,238, ordered by supporting articles. Choose a funder to see its evidence.
Cochrane Central Register of Controlled Trials12ProQuest12UK Health Security Agency12WHA12EMA11Scottish Government11NHSE11GMC11World Health Organisation11Medicines and Healthcare Products Regulatory Agency10UNAIDS10German Clinical Trials Register10International Olympic Committee10Office for National Statistics10US Centers for Disease Control and Prevention10pharmaceutical companies10ADA9NIH9IOC9CINAHL9Danish Medicines Agency9Gavi8Care Quality Commission8Department of Health and Social Care8European Commission8FDA-approved8Centers for Disease Control and Prevention8Danish Data Protection Agency8Institutional Ethics Committee8US government8VA7WHO-recommended7James Lind Alliance7AstraZeneca7UKHSA7British Thoracic Society7Institutional Review Board7National Comprehensive Cancer Network7National Health Service England7U.S. Food and Drug Administration7UK medical register7US Agency for International Development7Trusts6Veterans Affairs6ESPGHAN6USAID6American Heart Association6BSPGHAN6EBSCOhost6Integrated Care Boards6Medical Research Council6National Health Service Trusts6Pharmaceutical Benefits Scheme6RCEM6MOH5AHA5DOD5BSG5National Natural Science Foundation of China5drug companies5
Articles mentioning funders
5,089 articles · page 54 of 425BMAGMCGeneral Medical Council
…Martin Whyte, a paediatric trainee who was suspended from the BMA’s Resident Doctors Committee in April 20231 over tweets that re…
Agency for Science, Technology and ResearchNMRC OFYIRG23jan-0049IAF-PP T-MoVac Programmecolorectal cancerBioinformatics InstituteSingapore Immunology NetworkAgency for Science, Technology and Research
… the Bioinformatics Institute and Singapore Immunology Network, Agency for Science, Technology and Research (A*STAR). Our work is funded in part by the following grants: N…
88.4%
National Commission for Science and TechnologyMinistry of HealthNIH Office for Human Research ProtectionsUniversity of MarylandUniversity of Maryland Medical CenterAIC Kijabe Hospitalsolid tumorshematological malignanciesAKUHNChimeric antigen receptor (CAR) T-cell therapy+1 more
… (KH IERC-02718/2019). A research license was obtained from the National Commission for Science and Technology (NACOSTI/P/24/33420) and a material transfer permit obtained fr…
World Bankmelanomanon-small cell lungStomach cancerLancet OncolImmune Checkpoint Inhibitorskidneykidney cancerImmune checkpoint inhibitors
…incidence ratios (MIRs) are shown for four major cancers across World Bank income groups…
FDAInternational Council for HarmonisationFDA-recommendedcancer treatment
…dates to international guidance, including ICH Q5A(R2), reflect FDA’s push to reduce animal-based biosafety testing in favor of mol…
American-Italian Cancer FoundationCRIS Foundation Out-Back Fellowship ProgrammeNIH R01 CA238268Pancreatic Ductal Adenocarcinomapancreatic cancerMass General Brighamsolid tumorsMGH Cancer CenterCAR-T cell therapyrotein+2 more
…ociety of Medical Oncology (SEOM). FB received funding from the American-Italian Cancer Foundation (AICF) and the Italian Association for Cancer Research (AIRC). …
AdaptimmuneEnvision Pharma, Inc.lete-celsynovial sarcomaSySMRCLS
…nced SyS and MRCLS.Acknowledgements This analysis was funded by Adaptimmune. Writing and editorial support was by Chloe Koulouris, PhD, of …
Innovation and Technology FundNSFC/RGC Joint Research SchemeInnoHK Initiativepembrolizumabnasopharyngeal carcinomaNPCinduction immunotherapy
…g immunotherapy.Acknowledgements This work was supported by the Innovation and Technology Fund under the InnoHK Initiative, a major initiative of the Hong Kon…
FAPESPTrust in ScienceGSKcolon cancerCCimmunotherapy
…matory axes in high-risk patients.Acknowledgements Supported by FAPESP (grant numbers #21/00408-6; 2024/10964-1), GSK, and Trust in Sc…